This content is from: Premium
EcoR1 Is Launching a Second SPAC
The biopharma specialist’s hedge fund had another very strong year in 2020.
One of the hottest health care-related hedge funds is planning to launch its second blank-check company one month after its first one closed on a merger deal.EcoR1 Capital, headed by one-time Institutional Investor Hedge Fund Rising Star Oleg Nodelman, on Tuesday said in a regulatory filing that it is seeking
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.